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SUMMARY
Canine leishmaniosis (CanL) is a major veterinary concern and a public health issue. Serological data are essential for
disease management. Several antigens used in serological assays have specificity related problems preventing relevant
seropositivity values establishment. Herein we report significant seropositivity level disparity in a study cohort with
384 dogs from eight countries, for antigens traditionally used in CanL – soluble promastigote Leishmania antigens
(SPLA) and K39 recombinant protein (rK39): 43·8 and 2·9% for SPLA and rK39, respectively. To better understand
the reasons for this disparity, CanL-associated serological response was characterized using, for complement serological
evaluation, a ubiquitous antigen – soluble Escherichia coli antigens (SECAs). Using cohorts of CanL dogs and dogs
without clinical evidences of CanL from non-endemic regions of Portugal, the serological response of CanL animals
followed specific trend of seropositivity rK39 > SPLA>SECA absent in non-diseased animals. Using receiver operating
characteristic curve analysis, these characteristic trends were converted in ratios, SPLA/SECA, rK39/SECA and rK39/
SPLA, that presented high predictive for discriminating the CanL cohort that was potentiated when applied in a
scoring system involving positivity to four out of five predictors (rK39, SPLA, SPLA/SECA, rK39/SECA and rK39/
SPLA). In fact, this approach discriminated CanL with similar sensitivity/specificity as reference antigens, diminishing
seropositivity in European cohort to 1·8%. Ultimately, non-related antigens like SECA and seropositivity ratios
between antigens enable different perspectives into serological data focusing on the search of characteristic serological
signatures and not simple absolute serology values contributing to comprehensive serological status characterization.
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INTRODUCTION
Canine leishmaniosis (CanL), caused by Leishmania
infantum (syn. Leishmania chagasi), is endemic
in the Mediterranean basin, South America and
Southern Asia, being a major veterinary concern
(Saridomichelakis, 2009; Ready, 2010; Noli and
Saridomichelakis, 2014; Wylie et al. 2014). These
protozoamay also induce human visceral leishmania-
sis, making CanL not just a veterinary problem but
also a public health issue due to the zoonotic poten-
tial of the infection (Michalsky et al. 2007; Sousa
et al. 2011; Noli and Saridomichelakis, 2014).
CanL control is based on vaccination, transmission
prevention by the insect vectors and also diseased
animals treatment (Palatnik-de-Sousa, 2012;
Courtenay et al. 2014; Silva et al. 2014). The CanL
diagnosis is based on clinical signs and demonstra-
tion of infection by direct visualization of parasites
and/or genetic material in conjunction with quantita-
tive serology (Michalsky et al. 2007; Paltrinieri et al.
2010; Solano-Gallego et al. 2011). Of paramount
importance for disease management is the detection
of dogs that have no leishmaniosis specific signs but
are infected. It is well established that infected dogs
without clinical signs are capable of perpetuating
the zoonotic life cycle of the parasite (Molina et al.
1994; Moreno and Alvar, 2002). Therefore,
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low-accuracy serological assays can have significant
impact in the global strategy to combat disease pro-
gression originating seropositivity levels that are
not translatable into meaningful epidemiological
data influencing policies associated with specific
control measures. In fact, cumulative evidence
point to a low specificity (Sp) of several serological
assays that hamper the detection ofLeishmania infec-
tion in dogs (Gomes et al. 2008; Morales-Yuste et al.
2012; Arruda et al. 2016; Elshafie et al. 2016; Fraga
et al. 2016). Moreover, detection of L. infantum
vectors across central European countries like
Switzerland, Germany and Hungary (Naucke et al.
2008; Ready, 2010), in conjunction with global
warming, might open new areas to endemicity,
through the adaptation of the vectors to new latitudes
(Geisweid et al. 2013; Millan et al. 2014). In fact,
disease is advancing northwards, with reports of
infected animals in traditionally non-endemic areas
(Saari et al. 2000; Dujardin et al. 2008; Ready, 2010;
Miro et al. 2012; Carvalho et al. 2015; Maia and
Cardoso, 2015).Therefore,more than ever, it is essen-
tial to have adequate serosurveillance systems and
tools to monitor and control infection progression
into new regions.
Herein we evaluate serological response of an
uncharacterized cohort of animals from distinct geo-
graphical backgrounds to two knownLeishmania anti-
gens [soluble promastigote Leishmania antigens
(SPLA) and K39 recombinant protein (rK39)] to
determine the adequacy of these antigens for sero-
logical surveys in non-endemic regions. To exclude
any inter-laboratory variability, we used CanL-posi-
tive and negative cohorts of dogs to determine the
cut-offs that are able to distinguish diseased from
non-diseased animals for both antigens. The gener-
ated cut-offs were applied to the test cohort and
levels of seropositivity compared. The unrelated
soluble Escherichia coli antigen (SECA) was also used
to address the Sp of the serological response to the
Leishmania antigens. Finally, the ratios between the
cut-offnormalized responses to the antigenswere eval-
uated for their capacity topredict disease in the control
cohorts and then used as part of a scoring system that
addresses seropositivity with clinical value.
MATERIALS AND METHODS
Canine sera
Group CanL+ (n = 29): sera from dogs living in geo-
graphical regions of Portugal where CanL is
endemic, which were brought to a veterinary hos-
pital, clinic or anti-rabies campaign and that pre-
sented at least two clinical signs compatible with
the disease (viz. lymphadenomegaly, alopecia,
dermatitis, skin ulceration, keratoconjunctivitis,
onychogryphosis, lameness, epistaxis, anorexia and
weight loss). These animals were also seropositive
for anti-Leishmania antibodies by the direct agglu-
tination test (DAT) (cut-off titre = 400) and/or posi-
tive for the presence of amastigotes in bone marrow
or lymph node aspirates.
Group CanL− (n = 121): sera from dogs that
visited a veterinary clinic in a Portuguese region con-
sidered to be non-endemic for CanL, Serra da
Estrela mountain in central Portugal. All were sero-
negative by DAT (titre < 100).
Group Europe (n= 384): sera from dogs without
clinical information, with unknown serological status,
that visited veterinary clinics in several countries of
Europe, namely Denmark (n= 50), France (n= 50),
Germany (n= 47), Hungary (n= 47), the Netherlands
(n= 42), Poland (n= 50), Portugal (n= 50) and the
UK (n= 48).
Antigens
Three different antigens were used for enzyme-
linked immunosorbent assay (ELISA): SPLA,
SECA and Leishmania rK39. For SPLA, L. infan-
tum promastigotes were obtained as previously
described (Santarem et al. 2010). Parasites were
washed three times with phosphate-buffered saline
(PBS), pH 7·4 and centrifuged at 3500 g for 10
min at 4 °C. The pellet was resuspended in PBS con-
taining 1 mM phenylmethylsulfonyl fluoride
(PMSF) protease inhibitor and submitted to 10
freeze–thaw cycles for rupture of the parasites.
This suspension was centrifuged at 13 000 g for 30
min at 4 °C and the supernatant was recovered,
quantified by DC (detergent compatible)™ Protein
Assay (BioRad, Munich, Germany), and stored at
−80 °C in single aliquots.
The rK39 antigen obtained from Dr Steven Reed,
from Infectious Disease Research Institute (Seattle,
Washington, USA) was suspended in mili-Q water,
quantified and stored at−80 °C in single-use aliquots.
For SECA, E. coli DH5-α strain was plated in an
agar plate and incubated at 37 °C overnight (O/N).
Then, a colony was transferred to 10 mL of Luria
Bertani broth (Sigma-Aldrich, St. Louis, USA)
and incubated at 37 °C O/N. The next day, the
optical density (OD) of the culture was measured
at 600 nm (initial OD should be nearly 0·1) and
left to grow for 3 h. The culture was then centri-
fuged at 4000 g for 5 min. The pellet was resus-
pended in 1 mL of PBS containing 1 mM of PMSF
and submitted to 10 freeze–thaw cycles for rupture
of the bacteria. The suspension was then centrifuged
at 13 000 g for 30 min at 4 °C and the supernatant
was recovered, quantified by DC (detergent compat-
ible)™ Protein Assay (BioRad, Munich, Germany)
and stored at −80 °C in single-use aliquots.
ELISA
Ninety-six-well flat-bottom microtitre plates
(Greiner Bio-One, Frickenhausen, Germany) were
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coated with 50 µL of 0·1 M carbonate buffer, pH =
9·6, with 10 µg mL−1 of either SPLA or SECA, or
1 µg mL−1 of rK39. Plates were incubated O/N at 4
°C and blocked with 200 µL of PBS low-fat milk
(3%) at 37 °C for 1 h. Next, plates were washed with
PBS-Tween 0·05% (PBS-T), and the sera, positive
and negative controls, diluted at 1 : 1500 in PBS-T
low-fat milk (1%), were dispensed in triplicate (100
µL per well) and incubated at 37 °C for 30 min.
After a washing step, 100 µL per well of conjugate
secondary anti-dog IgG antibody conjugated with
horseradish peroxidase (Sigma, St. Louis, USA) –
diluted at 1 : 1176·5, was added and the plates were
incubated at 37 °C for 30 min. Plates were washed
and incubated with 0·5 mg mL−1 of o-phenylenedi-
amine dihydrochloride (Sigma, St. Louis, USA) for
10 min in dark. Reaction was stopped with 50 µL
per well of HCl (3 M). Absorbance was read at 492
nm in an automatic reader (Synergy 2, BioTek
Instruments, Winooski, USA).
All samples and antigens were assayed in at least
two independent assays.
Statistical analysis
Receiver operating characteristic (ROC) curves were
generated using sera from groups CanL+ and CanL−,
using GraphPad Prism version 5.00 for Windows,
GraphPad Software, San Diego California USA,
www.graphpad.com. A 95% confidence interval for
the area under the ROC curve was considered.
Cut-off values were inferred through these curves
for each antigen [by choosing the best compromise
between sensitivity (Se) and Sp associated with
the ROC curve], and values of Se, Sp, false negatives
(FN), false positives (FP), positive predictive value
and negative predictive value were calculated for
the samples for each group (Parikh et al. 2008).
Optical densities of each sample were normalized
by division with the corresponding cut-off value
(nSPLA, nrK39 and nSECA) and the logarithm of
this ratio was applied for graphical representation
[log(nSPLA), log(nrK39) and log(nSECA)]. The
cut-off normalized values (n) were used to assess
the ratio between the antigens: SPLA/SECA (ratio
between nSPLA and nSECA), rK39/SECA (ratio
between nrK39 and nSECA) and rK39/SPLA
(ratio between nrK39 and nSPLA). A score evalu-
ation method was established based on the cut-off
values inferred from the ROC curves for the ratios
and the single antigens. A binary score (1 or 0) was
applied to represent seropositivity (arbitrary value
of 1) or seronegativity (arbitrary value of 0) to the
five serological parameters previously established
and whose cut-off values was determined by ROC
curve analysis: rK39, SPLA, rK39/SECA, SPLA/
SECA and rK39/SPLA. Total cumulative score
for each individual sample ranged from ‘0’ to ‘5’
(Fig. 1).
RESULTS
ROC curve analysis was performed to define cut-off
values for rK39 and SPLA using sera from dogs
of CanL+ and CanL− groups (Supplementary
Fig. S1A, S1B and Table S1). Cut-off values for
rK39 and SPLA were 0·127 and 0·074, respectively.
These cut-offs enabled a Se of 100% (29/29) for both
antigens with Sp of 100% in both cases (0/121)
(Supplementary Table S1). When the cut-offs were
applied to the European cohort, they originated a
global seropositivity of 43·8% (168/384) and 2·9%
(11/384) for the individual antigens, SPLA and
rK39, respectively (Table 1, Fig. 2A–C). If seroposi-
tivity to both antigens was used as a requisite, then
2·3% (9/384) of the cohort was seropositive
(Table 1).
Observing the generated seropositivity data
disparity for antigens that excelled at discriminating
CanL from non-CanL dogs, two possibilities were
considered: either the SPLA was detecting FP or
rK39 was detecting FN. Considering that both anti-
gens presented very high Sp and Se, the cut-off
stringency was increased to decrease the number of
FP (Supplementary Table S2 and Fig. 3A). For
seropositivity associated with both antigens to have
Fig. 1. Evaluation of seropositivity of each individual serum evaluated as a cumulative score. Each individual serum was
‘scored’ as nSPLA+ nrK39 + nSECA+SPLA/SECA+ rK39/SECA+ rK39/SPLA using the following premise: each
serology value above or equal to the cut-off values of nSPLA, nrK39, nSECA, SPLA/SECA, rK39/SECA and rK39/
SPLA was transformed into a score of ‘1’ originating a cumulative score ranging from 0 to 5 to each individual sample.
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epidemiological relevance, then the increase in cut-
off stringency should enable a decrease of FP asso-
ciated with SPLA leading seropositivity levels
similar to rK39. In the European cohort, using two
cut-offs (cut-off value × 2) for rK39, the number of
seropositive animals is reduced to just one, PT30
(Fig. 3B). For SPLA, 66/384 (17·2%) animals
remained seropositive when two cut-offs were used
(Supplementary Table S2). Comparing these
SPLA-seropositive animals with the original 11
animals seropositive for rK39, only six animals
were seropositive to rK39 and SPLA using two
SPLA cut-offs (Fig. 3B). From 3 to 7 SPLA cut-
offs, only three animals were seropositive for both
antigens – when compared once again to the original
rK39-positive animals (Fig. 3B). The sample with
highest seropositivity to both antigens was PT30
(Fig. 3B).
The geographic distribution of seropositive
animals was not random, ranged from 0 to 86%.
Poland presented (43/50) seropositive animals,
while France presented 0/50 animals to SPLA
(Fig. 4 and Supplementary Table S2). Considering
the individual countries, rK39-seropositive animals
were mostly from Portugal: 66·3% (7/11) (Fig. 4A,
Supplementary Fig. S2A). Still, three animals were
from non-endemic countries [two from Denmark
(DK44 and 50) and one from Poland – PL9] and a
final one from France (FR2) (Fig. 3). For SPLA,
although there was also an over-representation of
dogs from Portugal (i.e. 12·5%; 21/168), this was
not as evident as for rK39 (Supplementary
Fig. S2). As the groups were proportional, the
basal cohort serological response was compared to
evaluate if existed a regional influence in the
response to the antigens (Supplementary Tables S3
and S4). For rK39, the dogs from Germany had a
basal median response significantly different from
Hungary and Portugal, while the animals from
Portugal were significantly different from all the
other cohorts (Supplementary Fig. S2A and
Table S3). For SPLA, more countries had signifi-
cant differences, with the cohort from Poland being
the most divergent (Supplementary Fig. S2 and
Table S4). As SPLA is an undefined antigen
mixture, these variations in seropositivity might cor-
respond to an unspecific response.
To address serological response Sp, an undefined
ubiquitous non-related antigen was used, E. coli
DH5-α, to evaluate if the serological response
pattern was similar to SPLA suggesting a general
unspecific response (Fig. 4A and Supplementary
Fig. S2B). The SECA antigen had some predictive
value to distinguish the control cohorts (Se of 81·5%
and Sp of 71·9%) (Fig. 4B and Supplementary
Table S1). Notwithstanding, the seropositivity
profile against SECA was distinct from the SPLA
(Fig. 4A, Supplementary Fig. S2B and Tables S4
and S5). To further address the relationship
between these antigens, correlations in the control
cohorts and also in each individual country were
done (Supplementary Table S6). In the CanL+
cohort, the highest correlation was obtained for
rK39 vs SPLA (r= 0·499, P< 0·01; r2 = 0·249),
whereas the lowest was for rK39 vs SECA (r =
−0·010, P= 0·952, r2 = 0·0001). In the CanL−
cohort, the highest correlation value was for SPLA
vs SECA (r= 0·356, P< 0·001, r2 = 0·127). At the
country level, the most common significant correl-
ation was SPLA vs SECA (3/8), while rK39 corre-
lated positively with SPLA in two countries and
with SECA in one country (Supplementary
Table S6). The cohort comparison at a country
level (absolute values and correlation data) suggests
distinct basal responses to the different antigens
influencing the serology absolute values.
To bypass the regional effects on the seropositiv-
ity, the ratios between the antigens were analysed
for their capacity to predict CanL in the control
cohorts. For this, the median normalized single-
antigen reactivity in the CanL+ control group was
compared (Figs 2 and 4B). The nrK39 and nSPLA
responses were higher than nSECA in CanL+
cohort. Moreover, this was characteristic of the
individual sera from the CanL+ cohort: (27/29) for
nSPLA> nSECA and (26/29) nrK39 > nSECA
(Supplementary Table S7). Likewise, the response
to rK39 was higher than to SPLA in (24/29) of the
cohort (Supplementary Table S7). Therefore, these
ratios, [log(nSPLA/nSECA) > 1; log(nrK39/
nSECA) > 1; log(nrK39/nSPLA) > 1] were charac-
teristic of CanL dogs (Supplementary Fig. S3).
Consequently, ROC curves analysis was performed
for each of the aforementioned individual ratios
(Supplementary Fig. S1D–F). The predictive value
of these ratios was considerable, although not super-
ior overall to the reference antigens alone
(Supplementary Table S1). The Sp of the ratios
Table 1. Seropositivity levels in the different study cohorts for SPLA and rK39 antigens
SPLA (%) rK39 (%) SPLA Λ rK39a (%) SPLA V rK39b (%)
CanL+ 100(29/29) 100(29/29) 100(29/29) 100(29/29)
CanL− 0(0/121) 0(0/121) 0(0/121) 0(0/121)
Europe 43·8(168/384) 2·9(11/384) 2·3(9/384) 44·3(170/384)
a Positive for both antigens simultaneously.
b Positive for at least one of the antigens.
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was 94·2, 92·6 and 72·7%, for nSPLA/nSECA,
nrK39/nSECA and nrK39/nSPLA, respectively
(Supplementary Tables S1 and S8). The lower Se
of the assays can be attributed to artefactual responses
due to low serological responders that create ratios
that are above the cut-off level (see PL38, FR9 and
DE47 in Supplementary Table S9). Therefore, the
capacity of these ratios to predict disease requires
the determination of positivity to reference antigens
to exclude the aforementioned artefactual values.
Taking this in consideration, a scoring system was
created to address not only the positivity to the refer-
ence antigens but also to the characteristic ratios
described above (Fig. 1). The Cohen’s κ coefficient
was determined for the possible scores to define the
best predictive value when compared to both refer-
ence antigens. The scores of 4 or 3 presented the
best predictive value (Supplementary Table S10).
We excluded the score 3 as it enabled positive
results that were negative for both reference antigens
(Fig. 1). This approach (using a score ⩾4) resulted in
an overall Se (96%) and Sp (100%) similar to the com-
bined reference antigens (Table 2). When this score
system was applied to our cohorts (Table 2), it
reduced the number of seropositive animals in the
European cohort to seven (PT10, PT30, PL9,
PL24, DK43, DK50 and FR2) with an overall
seropositivity of 1·8% (7/384) (Table 2 and
Supplementary Tables S9–12). This represents a
diminution of 36% in seropositivity when compared
with rK39 alone. We also report a diminution of
22% in seropositivity when compared with rK39
and SPLA combined (Table 1). Only one animal in
Europe presented a perfect score of 5 (PT30), the
most common score in the CanL+ cohort [82·8%
(24/29)], with the remaining six animals presenting
a score of 4. These seven seropositive animals from
the European cohort obtained after application of
the score methodology were all rK39-seropositive
animals with the exception of one sample from
Poland (PL24) (Supplementary Fig. S4 and
Table S9).
DISCUSSION
In the present study, the used antigens, SPLA and
rK39, are established antigens with reported high
sensitivities and specificities and are the base of
several reference tests. The cut-off values for two
antigens, using a cohort of CanL+ dogs and a
Fig. 2. Reactivity of CanL+, CanL− and European dog sera against SPLA and rK39 antigens (A). Correlation of the
seroreactivity against SPLA and rK39 antigens in CanL+ and CanL− cohorts (B) and in European cohort (C). Results are
expressed as the logarithm of the optical density (OD) at 492 nm normalized by the cut-off value for each antigen (n). Bars
represent the median for the cohort and each single dot represents the dataset for an individual dog. The data depicted were
generated from the average of at least two independent assays done in triplicate.
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cohort of CanL− dogs, were determined. The
obtained cut-offs were similar in absolute value to
the ones obtained in previous work from our group
(Santarem et al. 2010), in a clear indication that
both antigens are capable of consistently discrimin-
ating CanL+ from CanL− dogs. When the newly
determined cut-offs were applied to a cohort of
animals from Europe without clinical characteriza-
tion, a seropositivity that was distinct for both anti-
gens (43·8% for SPLA and 2·9% for rK39) was
obtained. This large difference in seropositivity
cannot be attributed to laboratory inter variability,
as all assays were performed in the same laboratory,
including the ROC curve analysis. The CanL
seropositivity levels reported for endemic
Mediterranean regions range between 5 and 30%
(Moreno and Alvar, 2002). The overall seropositiv-
ity levels obtained for the non-endemic countries
was not in accordance with epidemiological data
that do not support significant seropositivity levels
Fig. 3. Representation of seroreactivity against SPLA and rK39 antigens in CanL+ and CanL+ cohorts (A), and
European cohort (B). Vertical and horizontal dotted lines represent the number of cut-offs (n× cut-off) for each antigen.
The cut-off-dependent sensitivity is represented in (A) for SPLA and for rK39. Results are expressed as the logarithm of
the optical density (OD) at 492 nm normalized by the cut-off value for each antigen (n). Each single dot represents the
dataset for an individual dog. The data depicted were generated from the average of at least two independent assays done in
triplicate.
Fig. 4. Reactivity of dog sera against SECA antigen for: (A) individual countries Hungary (HU), The Netherlands (NL),
UK, Germany (DE), France (FR), Denmark (DK) and Poland (PL). Results are expressed as the logarithm of the optical
density (OD) at 492 nm normalized by the cut-off value for each antigen (n) and (B) CanL+, CanL− and European cohort.
Bars represent the median for the cohort and each single dot represents the dataset for an individual dog. The data depicted
were generated from the average of at least two independent assays done in triplicate. Statistical analysis was done by one-
way ANOVA and Kruskal–Wallis tests. Statistical significance between groups is ‘extremely significant’ (***0·0001⩽P <
0·001).
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in the non-endemic countries from the European
cohort (Solano-Gallego et al. 2011). The rK39 sero-
positivity levels are more in the range of what is
reported from the endemic regions, but still non-
endemic seropositive samples were identified in
Denmark and Poland. These positive animals
might be associated with canine population mobility
associated with travelling, an issue of growing
concern for CanL (Menn et al. 2010; Bart et al.
2013). Leishmania infantum is endemic in southern
European countries (Dujardin et al. 2008) that are
a highly valued vacation destination generally
during the peak of the transmission season. In
these conditions, the risk for exposure to the parasite
can be as high as 0·23% for dogs coming from nor-
thern Europe (Teske et al. 2002). In fact, the few
reported CanL cases in northern Europe are
restricted to dogs that have travelled to endemic
areas of the Mediterranean basin during periods
when phlebotomine sand fly exposure is high,
mostly between March and November, or that
have to be relocated from those areas (Saari et al.
2000).
SPLA in known to have cross-reactivity with other
diseases like babesiosis, Chagas, ehrlichiosis, rickett-
siosis and toxoplasmosis, probably due to some
epitope conservation generating unspecificity
(Gomes et al. 2008; Saridomichelakis, 2009;
Silvestre et al. 2009; Zanette et al. 2014; Peixoto
et al. 2015). This cross-reactivity was suggested
upon correlation of the data from SPLA with
SECA (Supplementary Table S6). In the cohorts
from three countries, there was a significant correl-
ation between SECA and SPLA, more than
between SPLA and rK39. This suggests that, in
the absence of a Leishmania-specific serological
response, the SPLA might also be recognized by
other non-related infectious diseases or immune
disorders. This is also suggested by the correlation
existing in the CanL− control group for these two
antigens. Still, the distinct pattern of basal recogni-
tion between SPLA and SECA (Fig. 4A and
Supplementary Fig. S2B) is not suggestive of
general unspecific recognition due to immunological
disorders, like polyclonal activation. Intriguingly, it
will also be important to address if the apparent
lack of Sp of SPLA might also be true for other
assays that use parasite total antigens, such as
IFAT or DAT. The rK39 was less prone to cross-
reactivity (Fig. 3B). In fact, the general basal
serological response was more uniform. This is in
agreement with the recognized value of rK39 as a
good serological marker for leishmaniosis (Porrozzi
et al. 2007). Still, regional differences in antigen
performance have been already reported, the
performance of rK39 (for the human visceral
leishmaniasis) is known to be diminished in sub-
Saharan Africa (Pattabhi et al. 2010; Bezuneh et al.
2014; Mukhtar et al. 2015). Subtle genetic
differences in Leishmania strains are sufficient to
influence the performance of the recombinant
antigens (Abass et al. 2015).
The adjustment of the cut-off stringency is often
used to help in the diagnosis of CanL (Paltrinieri
et al. 2010). Therefore, we increased the cut-off strin-
gency (at the cost of decreased Se) (Fig. 3A). Two
cut-offs decreased the global seropositivity for
SPLA and rK39 to 66/384 (17·2%) and 1/384
(0·26%), respectively. Still, a significant difference
in readout between both antigens was apparent, as
there was no correspondence between SPLA- and
rK39-seropositive animals. In fact, the increase in
SPLA cut-off stringency also led to a loss of rK39-
positive animals (standard cut-off), instead of
having an enrichment of double positive sera as
would be expected for seropositivity related to
CanL. Still, it must be referred that existence of
dogs with different clinical stage of the disease
might also contribute to distinct levels of seropositiv-
ity to rK39 and SPLA. It was shown for naturally
infected dogs that rK39, although adequate for
detecting symptomatic infections, presented lower
capacity to evaluate sub-clinical infections
(Santarem et al. 2010). This could justify the failure
in enrichment for double positive animals with the
cut-off increase. Still, as most countries in the study
are non-endemic (exception of Portugal and
France), natural exposure to the parasite and asymp-
tomatic infections should not be a decisive factor for
the lack of correspondence in seropositivity levels.
To address the possibility of unspecificity of
SPLA in the European cohort, SECA was used as
a measure of the humoural response that is not spe-
cifically directed to Leishmania. Although SECA has
some predictive value (probably as a consequence of
some level of conservation at the epitope level or due
to, in severe cases of the disease, polyclonal activa-
tion and effects of co-infections), it presented low
Sp (71·9%). Upon cut-off normalization, it was also
evident the clear relationships between the antigens.
The median normalized response of the animals of
Table 2. Seropositivity levels in the different study
cohorts using the scoring system
Score
‘5’a (%) ‘4’b (%) Totalc (%)
CanL+ 82·8(24/29) 13·8(4/29) 96·5(28/29)
CanL− 0·0(0/121) 0·0(0/121) 0·0(0/121)
Europe 0·3(1/384) 1·6(6/384) 1·8(7/384)
a 5: seropositivity to all serological parameters defined in
Fig. 1.
b 4: seropositivity to four out of five serological of the
parameters defined in Fig. 1.
c Total: seropositivity to at least four out of the parameters
defined in Fig. 1.
1390Carla Lima and others
https://doi.org/10.1017/S0031182017000713
Downloaded from https://www.cambridge.org/core. U. Porto, on 19 Dec 2017 at 12:26:07, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
the CanL+ control group was highest for rK39 and
lowest for SECA (Figs 2A and 4B). This character-
istic seropositivity pattern rK39 > SPLA>SECA
was also evident for the individual animals
(Supplementary Table S8). This was suggestive
that the relation between the antigens might have
predictive value for the detection of CanL. If fact,
the relationship between the three antigens
(nSPLA/nSECA, nrK39/nSECA, nrK39/nSPLA)
presented significant predictive power, as deter-
mined be ROC curve analysis (Supplementary
Table S1). Still, their direct application in the
European cohort did not result in a diminution of
seropositivity (Supplementary Table S8). This was
not unexpected because the relation is independent
on absolute values. Therefore, very low serological
results might be seropositive using this approach.
Therefore, the unrestricted use of antigen seroposi-
tivity ratios present a significant risk of irrelevant
artefactual values. Still, these data clearly established
that the ratios between the antigens followed a
pattern that is in conjunction with positivity to one
or both reference antigens was found to be predictive
of CanL+ (Fig. 1).
When applied to the European cohort, the score
approach originated a global seropositivity of 1·8%
(7/384). These seven animals were indistinguishable
from the CanL+ cohort in at least four evaluated
characteristics (one presented a perfect score of 5).
This was the animal sorted upon the increase of
rK39 threshold (PT30). Only one animal from
Poland (PL24), which was classified with a score of
4, was not positive for rK39 alone. This sample
was positive for SPLA and for the three ratios eval-
uated in the score system (nSPLA/nSECA, nrK39/
nSECA and nrK39/nSPLA). Although the absolute
value of the OD to rK39 was below the cut-off
(0·127) for this sample, this difference was only
0·021 (see PL24 in Supplementary Table S9). This
is a clear example of problems associated with
using absolute values. Subtle differences can place
a serum in opposite sides of the threshold. For
example, PT45 was seropositive for rK39, having
0·134 of average OD. Still, in our score system, it
was negative with only a score of 3 due to a dispro-
portionally high response to SECA and SPLA
(Supplementary Table S9). The high reactivity to
SECA prevented positive ratios and consequently
preventing the higher score. This very high relative
reactivity to SECA was not characteristic of our
CanL+ cohort. PT34 is another interesting sample
with overall high responses to all tested antigens
with average ODs of 0·659 for SECA, 0·447 SPLA
and 0·147 for rK39. Once again, this profile is not
characteristic of the infected cohort and might
reflect auto-immunity or other complications or a
different stage of disease.
In the CanL+ group also, some samples are
mentionworthy. The CanL+ 4 is the sample that
prevents a 100% Se for the score approach. This is
the sample with the highest SECA average OD
(2·455). This might be due to an already advanced
stage of the disease resulting in the loss of the char-
acteristic serological pattern of active disease due to
other co-infections or even polyclonal activation.
The presented data demonstrate that the evalu-
ation of seropositivity is a complex issue that is
often oversimplified. We report that complex
mixtures of antigens like SPLA are prone to cross-
reactivity making them more unreliable for serosur-
veillance studies than rK39. Recombinant antigens
like rK39 were less afflicted by regional-specific
serological background and still might be more sen-
sitive to subtle strain-specific changes in the native
antigen. The use of ratios associated with serological
responses to specific antigens can be used to create
more accurate serological profiles that might
contribute for identification of infected animals.
Disease-specific serological footprints might be
exploited to better understand the immune
responses of clinically and sub-clinically infected
and/or merely exposed animals, enabling early
warning system for disease development and more
accurate serosurveillance studies. Further studies
with different recombinant antigens and experimen-
tally infected animals and cohorts of animals with
different clinical status will validate these observa-
tions and help to overcome the reported failure of
complex antigens mixtures (SPLA) and recombin-
ant proteins (rK39) in establishing meaningful
seropositivity levels.
SUPPLEMENTARY MATERIAL
The supplementary material for this article
can be found at https://doi.org/10.1017/S003118
2017000713.
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